Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Nasdaq Biotechnology Ishares ETF
(NQ:
IBB
)
144.77
-0.83 (-0.57%)
Official Closing Price
Updated: 4:15 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nasdaq Biotechnology Ishares ETF
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
You Don't Have to Pick a Winner in Biotech. Here's Why.
November 18, 2023
If you invest over the long term, you'll increase your chances of victory.
Via
The Motley Fool
Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures
November 09, 2023
Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.
Via
InvestorPlace
Healthcare Playbook: Hardly Defensive With A Covid Hangover In Biotech
November 01, 2023
Market Bubbles may take a long time to clear and we created a big one in July 2021 dealing with the COVID pandemic.
Via
Talk Markets
Exposures
COVID-19
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
October 23, 2023
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at...
Via
Talk Markets
Topics
Economy
Exposures
Economy
When News Moves So Fast, Stocks Can Stand Still
October 16, 2023
As far as the market goes, it feels like time is standing still.
Via
Talk Markets
Three Lessons For Investing In Biotech Companies
August 23, 2023
Many successful blockbusters started with a small trial. But you should temper your expectations until a larger, more rigorous trial is conducted.
Via
Talk Markets
Johnson & Johnson Stock: Is Now the Time to Sell?
October 14, 2023
Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff
Via
InvestorPlace
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
October 09, 2023
Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment.
Via
Talk Markets
Fresh Look At Long Bonds
September 14, 2023
As long as the S&P 500 outperforms long bonds (TLT) risk is on.
Via
Talk Markets
Topics
Bonds
Stocks
Exposures
Debt Markets
US Equities
Healthcare Playbook Revisited - Growth Plus Value
September 13, 2023
Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on.
Via
Talk Markets
Time For Gilead Sciences-Heavy ETFs?
September 12, 2023
Gilead Sciences has underperformed the broader market this year by a hefty margin.
Via
Talk Markets
Technical Correction Or Return Of The Bear Market?
September 06, 2023
The QQQ chart right now has a few key aspects.
Via
Talk Markets
It’s Really All About the Retail Sector Now
September 05, 2023
Should XRT break the July calendar range low, we will once again be talking about the 80-month moving average or the 6–7-year business cycle low.
Via
Talk Markets
The 3 Best Biotech Stocks to Buy Now: September 2023
September 04, 2023
With the biotech sector looking poised to continue its rally further, investors would do well to buy these stocks to capitalize.
Via
InvestorPlace
Industry ETFs In The Spotlight: Winners And Losers Of The Month Revealed
August 31, 2023
Via
Benzinga
Topics
ETFs
Life Science Mutual Funds Compared To ETFs And What Is In Your Portfolio?
August 30, 2023
It is important to track sectors of the market because trends to create volatility. For example the COVID pandemic created a diagnostics and vaccine revenue bubble that dissipated over several months.
Via
Talk Markets
Topics
ETFs
Exposures
COVID-19
BRICS And The Recent Headline
August 23, 2023
At a time when the world is experiencing de-globalization, an alliance of countries including Brazil, Russia, China, South Africa and possibly India is a potential threat to the west.
Via
Talk Markets
The US Dollar And Long Bonds Doing The Dosey Doe
August 22, 2023
With BRICS happening ahead of Jackson Hole, it would be good to look at the technical charts on both the dollar and the long bonds.
Via
Talk Markets
5 Meme Stocks to Sell Immediately, According to AI
August 22, 2023
As we move into September, the MarketMaster AI is flashing warning signals about risky equities. Sell these meme stocks right now.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Biotechnology On Drugs
August 21, 2023
Biotechnology has traded basically sideways since the start of 2023.
Via
Talk Markets
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
August 21, 2023
Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years.
Via
Talk Markets
3 Strong Biotech Performers To Watch As Sector Nears Breakout
August 17, 2023
As the IBB ETF nears a potential breakout, watch for strong performers like Regeneron Pharmaceuticals, Vertex, and Exelixis to continue outperforming.
Via
MarketBeat
Topics
ETFs
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.
Via
InvestorPlace
Weight-Loss Drug Wegovy Adds Mass To Novo Nordisk's stock, Pushing Valuation Past Denmark's GDP
August 12, 2023
Via
Benzinga
CPI-Market Impact Now And Later?
August 10, 2023
A discussion about inflation, bonds, calendar ranges, and places to park your money
Via
Talk Markets
Topics
Bonds
Economy
Exposures
Debt Markets
Interest Rates
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss
August 10, 2023
The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.
Via
Benzinga
Topics
ETFs
Economy
Exposures
Interest Rates
5 Magnificent ETFs to Buy Hand Over Fist for the Second Half of 2023
August 08, 2023
These exchange-traded funds (ETFs) offer low or ultralow net expense ratios and are perfectly positioned to help investors grow their wealth.
Via
The Motley Fool
The July 6-Month Calendar Range SPY QQQ IWM TLT
July 26, 2023
Looking at the SPY chart, we have had 7 trading days above the range high. However, to date, SPY has not really taken off from that level and sits more in consolidation mode.
Via
Talk Markets
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
July 31, 2023
Via
Benzinga
Now That The July 6-Month Calendar Range Is Set
July 24, 2023
As this week begins with a test of the July 6-month calendar range high, should that level break down, it could mean a substantially wide trading range in store for the small caps.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.